Moreover, lysine acetylation of NKG2D ligand Rae-1 at K80 and K87 sensitizes tumor cells to NKG2D immune surveillance via NKG2D stabilization that involves both adaptive and innate immune responses [72]. Here, KLRK1 is linked to neoplasm.